Skip to main content

Want a detailed portfolio tracker?

Ventyx Biosciences (VTYX) P/E (2021 - 2026)

Ventyx Biosciences (VTYX) P/E from Dec 31, 2021 to Mar 4, 2026. The TTM Ventyx Biosciences (VTYX) P/E is -9.35. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ventyx Biosciences (VTYX)

YearP/EChange
2026-9.35+55.04%
2025-6.03+426.23%
2024-1.15+44.23%
2023-0.79-95.80%
2022-18.93-66.39%
2021-56.34N/A

Comparison Ventyx Biosciences (VTYX) P/E with competitors

Ventyx Biosciences (VTYX) P/E is -9.35.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.80%
FGENFibroGen Inc0.24-102.57%
CHRSCoherus Biosciences Inc0.85-109.07%
FBIOFortress Biotech Inc0.95-110.15%
ORMPOramed Pharmaceuticals Inc1.50-116.07%
AGENAgenus Inc3.01-132.18%
INVAInnoviva Inc3.15-133.73%
CRMDCorMedix Inc3.63-138.80%
CVACCureVac N.V.4.45-147.54%
GLPGGalapagos NV4.86-151.96%
SRPTSarepta Therapeutics Inc4.88-152.21%
ABEOAbeona Therapeutics Inc5.39-157.61%
ABUSArbutus Biopharma Corp5.60-159.84%
ZVRAZevra Therapeutics Inc5.89-162.96%
SPROSpero Therapeutics Inc6.23-166.60%
CGENCompugen Ltd6.31-167.52%
RIGLRigel Pharmaceuticals6.87-173.49%
SLXNSilexion Therapeutics Corp7.30-178.02%
OMEROmeros Corporation9.26-199.01%
AUPHAurinia Pharmaceuticals Inc9.58-202.50%
PLXProtalix BioTherapeutics Inc10.89-216.46%
ACADAcadia Pharmaceuticals Inc11.73-225.42%
TBPHTheravance Biopharma Inc12.26-231.13%
ADMAAdma Biologics Inc12.42-232.79%
HRMYHarmony Biosciences Holdings Inc13.82-247.79%
SABSSAB Biotherapeutics Inc14.14-251.17%
NAGENiagen Bioscience Inc14.82-258.46%
INCYIncyte Corp15.82-269.20%
REGNRegeneron Pharmaceuticals Inc15.86-269.56%
PBYIPuma Biotechnology Inc17.32-285.17%
CPRXCatalyst Pharmaceuticals Inc17.44-286.49%
EXELExelixis Inc17.54-287.54%
TGTXTG Therapeutics Inc18.97-302.81%
MDXGMimedx Group Inc20.55-319.78%
XOMAXOMA Royalty Corp22.87-344.62%
ARGXArgen X SE24.30-359.84%
CTMXCytomX Therapeutics Inc24.82-365.43%
XOMAOXOMA Royalty Corp25.34-371.03%
HALOHalozyme Therapeutics Inc25.62-374.02%
XOMAPXOMA Royalty Corp25.67-374.51%
VRTXVertex Pharmaceuticals Inc27.99-399.37%
RPRXRoyalty Pharma plc - Class A28.69-406.78%
SLNOSoleno Therapeutics Inc29.02-410.28%
ASNDAscendis Pharma A/S30.09-421.73%
LGNDLigand Pharmaceuticals Inc - Class B37.91-505.42%
APLSApellis Pharmaceuticals Inc39.02-517.29%
BMRNBiomarin Pharmaceutical Inc42.21-551.41%
KRYSKrystal Biotech Inc45.34-584.90%
ONCBeiGene Ltd69.54-843.65%
PHARPharming Group N.V.75.03-902.31%
TECHBio-Techne Corp101.96-1190.33%
VCELVericel Corp109.92-1275.48%
ALNYAlnylam Pharmaceuticals Inc117.96-1361.50%
GMABGenmab140.29-1600.25%
TLXTelix Pharmaceuticals Ltd162.15-1834.03%
CORTCorcept Therapeutics Inc212.86-2376.26%